SCHEMBL3394684

SCHEMBL3394684

O=C1CC/C=C\CCCC(=O)CCC1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 2/20 0.47
TRIM33 Q9UPN9 2/20 0.47
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3393321 1.00 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL3697467 1.00 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL16417514 0.97 TRIM24 (0.50) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL1566775 0.97
SCHEMBL1566776 0.97
SCHEMBL7917256 0.97
SCHEMBL16417515 0.94 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL16417516 0.94 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL1014666 0.94 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT
SCHEMBL819987 0.94 TRIM24 (0.47) TRIM24TRIM33ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2391596-B1 METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING BASF SE (DE) 2018-06-20 EP disclosed
US-8212082-B2 Process for the isolation of dodecatrienal and its use as aroma substance BASF SE (DE) 2012-07-03 US disclosed
US-8212082-B2 Process for the isolation of dodecatrienal and its use as aroma substance BASF SE (DE) 2012-07-03 US disclosed
US-8212082-B2 Process for the isolation of dodecatrienal and its use as aroma substance BASF SE (DE) 2012-07-03 US disclosed
US-8188320-B2 Process for preparing pure cyclododecanone BASF SE (DE) 2012-05-29 US disclosed
US-8188320-B2 Process for preparing pure cyclododecanone BASF SE (DE) 2012-05-29 US disclosed
US-8188320-B2 Process for preparing pure cyclododecanone BASF SE (DE) 2012-05-29 US disclosed
EP-2391597-A1 METHOD FOR PRODUCING PURE CYCLODODECANONE BASF SE (DE) 2011-12-07 EP disclosed
EP-2391596-A1 METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING BASF SE (DE) 2011-12-07 EP disclosed
WO-2010086314-A1 METHOD FOR PRODUCING PURE CYCLODODECANONE BASF SE (DE) 2010-08-05 WO disclosed
WO-2010086313-A1 METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING BASF SE (DE) 2010-08-05 WO disclosed
WO-2010086314-A1 METHOD FOR PRODUCING PURE CYCLODODECANONE BASF SE (DE) 2010-08-05 WO disclosed
WO-2010086313-A1 METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING BASF SE (DE) 2010-08-05 WO disclosed
US-20100190869-A1 PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE BASF SE (DE) 2010-07-29 US disclosed
US-20100190869-A1 PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE BASF SE (DE) 2010-07-29 US disclosed
US-20100190869-A1 PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE BASF SE (DE) 2010-07-29 US disclosed
US-20100191018-A1 PROCESS FOR PREPARING PURE CYCLODODECANONE BASF SE (DE) 2010-07-29 US disclosed
US-20100191018-A1 PROCESS FOR PREPARING PURE CYCLODODECANONE BASF SE (DE) 2010-07-29 US disclosed
US-20100191018-A1 PROCESS FOR PREPARING PURE CYCLODODECANONE BASF SE (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100191018-A1 PROCESS FOR PREPARING PURE CYCLODODECANONE CCNA1, CYC1, CCNA2 TRIM24 3392/4885TRIM33 4369/4885ALDH1A1 503/4885
US-20100190869-A1 PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE CCNA1, OXER1, CCNA2 TRIM24 2928/4885TRIM33 4416/4885ALDH1A1 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.